YC-backed Perlstein Lab continues their rare disease drug discovery

 Perlstein Lab, or PLab as it is also known, continues to hone its automated drug discovery platform and presents its latest iteration Wednesday March 23rd at Y Combinator Demo Day. The platform they created helps the bio startup focus on finding cures for rare diseases rather than common ones. This novel approach is different from most Big Pharma labs and is thus one of their differentiators. Read More

http://ift.tt/1S8oQbf YC-backed Perlstein Lab continues their rare disease drug discovery http://ift.tt/1pyKgpf